Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.
<h4>Background</h4>Rates of oropharyngeal cancer (OPC) associated with alcohol & tobacco use have decreased, while human papillomavirus (HPV) associated OPC has increased among men in the US. Secretory leukocyte protease inhibitor (SLPI), detectable in a variety of secretions, has be...
Guardado en:
Autores principales: | Brittney L Dickey, Bradley Sirak, Laura Martin-Gomez, Richard R Reich, Martha Abrahamsen, Kimberly Isaacs-Soriano, Christine H Chung, Anna R Giuliano |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef3b1aeae8964c278ab48c2ed0cc7904 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane.
por: Bénédicte Py, et al.
Publicado: (2009) -
Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion
por: Takumi Kishimoto, et al.
Publicado: (2021) -
SLPI is a critical mediator that controls PTH-induced bone formation
por: Akito Morimoto, et al.
Publicado: (2021) -
Protease Inhibitor and Metabolic Alteration
por: Cavenaghi,F. M, et al.
Publicado: (2012) -
Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis.
por: Sumant Puri, et al.
Publicado: (2012)